← Eichor
Condition: Drug Related Side Effects And Adverse Reactions Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Drug Related Side Effects And Adverse Reactions

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac
Phase 3 · 590 location(s) · SWOG Cancer Research Network · NCT03418961Cardiovascular Health in Adult Patients With Cancer Exposed to Cardiotoxic Therapies
Phase N/A · 1 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT06664528Prospective Comparative Validation Study of RUCAM and RECAM
Phase N/A · 1 location(s) · Beijing Friendship Hospital · NCT06771011Prospective Cohort of Immune Checkpoint Inhibitor-induced Hepatitis
Phase N/A · 1 location(s) · University Hospital, Montpellier · NCT06864481A Prognostic Model for Drug-induced Liver Injury in China
Phase N/A · 13 location(s) · Beijing Friendship Hospital · NCT05060289Cardiovascular Prevention Strategies in Elderly Patients With Cancer (CARTIER Clinical Trial)
NA · 14 location(s) · Fundación Instituto de Estudios de Ciencias de la Salud de C · NCT03711110Photobiomodulation Therapy in the Management of Hand-foot Syndrome and Hand-foot Skin Reaction
NA · 2 location(s) · Jessa Hospital · NCT04979078The CARDIOPROTECT Trial
Phase 2 · 1 location(s) · Beth Israel Deaconess Medical Center · NCT07654426Routinely Collected Clinical Data and Evaluation of Antimicrobial Target Attainment
Phase N/A · 1 location(s) · Imperial College London · NCT06427317Protective Effects of the Nutritional Supplement Sulforaphane on Doxorubicin-Associated Cardiac Dysfunction
Phase 1/Phase 2 · 1 location(s) · Texas Tech University Health Sciences Center · NCT03934905Impact of Genetic Variants on the Toxicity of Antibody-Drug Conjugates in Locally Advanced or Metastatic Breast Cancer:
Phase N/A · 1 location(s) · Fundación Pública Andaluza para la Investigación Biomédica A · NCT07582887Propofol and Etomidate Admixtures Comparisons Trial (PEAC Trial)
Phase 3 · 1 location(s) · University of Texas Southwestern Medical Center · NCT05358535Cardiotoxicity of Carbon Monoxide in Patients Treated With Hyperbaric Oxygen Therapy
Phase N/A · 1 location(s) · University Hospital, Brest · NCT06549621Chemotherapy-induced Cognitive and Brain Changes in Older Adults With Breast Cancer
NA · 2 location(s) · Massachusetts General Hospital · NCT02290834A Prospective Cohort Study on Drug-induced Liver Injury in China（DILI-P）
Phase N/A · 1 location(s) · Drug Induced Liver Disease Study Group · NCT02961413Prevention of Ototoxicity in NTM Patients Treated With IV Amikacin
Phase 2 · 8 location(s) · Kevin Winthrop · NCT05730283Sacubitril/Valsartan in PriMAry preventIoN of the Cardiotoxicity of Systematic breaST canceR trEAtMent (MAINSTREAM)
Phase 4 · 4 location(s) · Silesian Centre for Heart Diseases · NCT05465031Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted
Phase 2 · 10 location(s) · Rutgers, The State University of New Jersey · NCT05559164ATROPOS: Survival Analysis of ICI-associated Myocarditis
Phase N/A · 1 location(s) · Groupe Hospitalier Pitie-Salpetriere · NCT07633587The Effect of Cancer Treatments on Speech Perception in Noise, Cognition, and Hearing-Related Quality of Life
Phase N/A · 1 location(s) · Turku University Hospital · NCT06551857Gut Microbiota and Diarrhea in Breast Cancer Patients Receiving Pyrotinib
Phase N/A · 1 location(s) · Hubei Cancer Hospital · NCT07264985Chemokeyp: A Feasibility Study for Realtime Safety Data-Capture for Potential Serious Adverse Drug Events
Phase N/A · 1 location(s) · St Vincent's University Hospital, Ireland · NCT07592234Generation of Heart Muscle Cells From Blood or Skin Cells of Breast Cancer Patients
Phase N/A · 1 location(s) · Memorial Sloan Kettering Cancer Center · NCT02772367Deutetrabenazine Treatment for Tardive Dyskinesia in Intellectual/Developmental Disabilities
Phase 4 · 1 location(s) · University Hospitals Cleveland Medical Center · NCT06997198Penicillin Allergy Delabeling After a One-Dose Versus Two-Dose Graded Direct Oral Challenge
Phase 3 · 1 location(s) · James Tarbox, MD · NCT06303128Role of Sodium-glucose Linked Transporter 2 (SGLT2) and Its Inhibitor Over CARdiotoxicity Induced by Anthracyclines and
Phase N/A · 1 location(s) · Centre Paul Strauss · NCT06443645Pharmacogenetics of Antidepressant-Induced Disinhibition
Phase N/A · 1 location(s) · University of Calgary · NCT03953014Carotid Artery Corrected Flow Time and Inferior Vena Cava Collapsibility Index for Prediction of Hypotension After Induc
Phase N/A · 1 location(s) · Tanta University · NCT06814054Adverse Drug Events in Patients on Oral Anticoagulation in the Emergency Department
Phase N/A · 1 location(s) · Centre Hospitalier Universitaire de Besancon · NCT06692504Cardiac Magnetic Resonance Monitoring of Immune Checkpoint Inhibitor-related Cardiotoxicity
Phase N/A · 1 location(s) · West China Second University Hospital · NCT06132984
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.